Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
allergan
4
×
clinical trials
fda
life sciences
national blog main
national top stories
new york blog main
abbvie
amgen
biohaven
biotech
boston blog main
boston top stories
eli lilly
migraine
national
new york top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
alder biopharmaceutical
american academy of neurology
atogepant
big pharma
bob azelby
botox
boulder/denver blog main
boulder/denver top stories
brian abrahams
bristol-myers squibb
calcitonin gene-related peptide
cgpr
clinical data
detroit blog main
detroit top stories
drugs
eptinezumab
erenumab
europe blog main
What
new
4
×
fda
approved
class
drug
migraine
adults
allergan
approval
approves
arguments
benefit
big
commercialized
companies
competitors
data
decades
disease
drop
drops
drugs
eye
fatty
glasses
horizon
intercept
kind
known
liver
make
marketed
medicine
medicines
meeting
millions
monday
nash
needing
neuro
Language
unset
Current search:
allergan
×
new
×
@extremetech.com
2 years ago
FDA Approves New Eye Drops that Could Replace Glasses for Millions
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
4 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
With New Data, Intercept On Track for First-Ever Approved NASH Drug
